Bioresponsive polyphenol-based nanoparticles as thrombolytic drug carriers
Thrombolytic (clot-busting) therapies with plasminogen activators (PAs) are first-line
treatments against acute thrombosis and ischemic stroke. However, limitations such as …
treatments against acute thrombosis and ischemic stroke. However, limitations such as …
Bioresponsive Polyphenol-Based Nanoparticles as Thrombolytic Drug Carriers
H Yu, J Palazzolo, J Zhou, YJ Ju - ACS Applied …, 2022 - researchrepository.rmit.edu.au
Thrombolytic (clot-busting) therapies with plasminogen activators (PAs) are first-line
treatments against acute thrombosis and ischemic stroke. However, limitations such as …
treatments against acute thrombosis and ischemic stroke. However, limitations such as …
Bioresponsive Polyphenol-Based Nanoparticles as Thrombolytic Drug Carriers
H Yu, JS Palazzolo, J Zhou, Y Hu… - … applied materials & …, 2022 - pubmed.ncbi.nlm.nih.gov
Thrombolytic (clot-busting) therapies with plasminogen activators (PAs) are first-line
treatments against acute thrombosis and ischemic stroke. However, limitations such as …
treatments against acute thrombosis and ischemic stroke. However, limitations such as …
Bioresponsive Polyphenol-Based Nanoparticles as Thrombolytic Drug Carriers
H Yu, JS Palazzolo, J Zhou, Y Hu… - ACS Applied …, 2022 - research.monash.edu
Thrombolytic (clot-busting) therapies with plasminogen activators (PAs) are first-line
treatments against acute thrombosis and ischemic stroke. However, limitations such as …
treatments against acute thrombosis and ischemic stroke. However, limitations such as …
[PDF][PDF] Bioresponsive Polyphenol-Based Nanoparticles as Thrombolytic Drug Carriers
H Yu, JS Palazzolo, J Zhou, Y Hu, B Niego, S Pan, Y Ju… - minerva-access.unimelb.edu.au
dspace cover page Page 1 1 Bioresponsive Polyphenol-Based Nanoparticles as
Thrombolytic Drug Carriers Haitao Yu,a,‡ Jason S. Palazzolo,b,‡ Jiajing Zhou,a,‡ Yingjie …
Thrombolytic Drug Carriers Haitao Yu,a,‡ Jason S. Palazzolo,b,‡ Jiajing Zhou,a,‡ Yingjie …
Bioresponsive Polyphenol-Based Nanoparticles as Thrombolytic Drug Carriers.
H Yu, JS Palazzolo, J Zhou, Y Hu, B Niego… - … Applied Materials & …, 2022 - europepmc.org
Thrombolytic (clot-busting) therapies with plasminogen activators (PAs) are first-line
treatments against acute thrombosis and ischemic stroke. However, limitations such as …
treatments against acute thrombosis and ischemic stroke. However, limitations such as …